Browsing: Psychedelics

For decades, one of the most standardized practices in medical and scientific research has been the use of placebos. No, we’re not talking about the 2000s…

An international survey Updated in JAMA Network Open revealed that cannabis and psychedelics such as psilocybin and LSD were perceived as more effective in relieving symptoms…

We are headed out to beautiful Cannon Beach, Oregon again this weekend for the Sixth Annual Northwest Cannabis and Psychedelics Law Conference. Harris Sliwoski attorneys Matt…

Boxing legend Mike Tyson attributes his remarkable recovery from physical and mental health challenges, as well as his return to the boxing ring, to the therapeutic…

A newly published study from researchers at New York University found that individuals dealing with a stutter derived some benefit from substances such as psilocybin, the…

Psychedelics policy reform advocates in California are calling for a ballot initiative to legalize certain drugs including psilocybin and MDMA after legislative attempts at change failed…

On May 17, Maryland Gov. Wes Moore signed two bills that will create a psychedelic task force, called the “Task Force on Responsible Use of Natural…

Big Tech is a hotbed for psychedelic microdosing—especially among the highest ranking thought leaders. So-called “tech bros” are gulping down microdoses of psychedelics, be it LSD,…

A study published in September in the journal Psychedelic Medicine found a majority of respondents – randomly selected American Psychiatric Association (APA) members – moderately or…

COMPASS Pathways, a biotechnology company dedicated to innovation in mental health, gained $285 million in private funding to research psychedelics, Behavioral Health Business reports. This amount…